Home
About
Overview
Sharing Data
ORCID
Help
History (51)
A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinoma.
Distinct roles for C3a and C5a in complement-induced tubulointerstitial injury.
Gibberellins
Nursing Methodology Research
Evolution of biologic therapies for the treatment of psoriasis.
See All 51 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Evolution of biologic therapies for the treatment of psoriasis.
Evolution of biologic therapies for the treatment of psoriasis. Skinmed. 2003 Sep-Oct; 2(5):286-94.
View in:
PubMed
subject areas
Biological Therapy
Cyclosporine
Drug Therapy, Combination
Female
Forecasting
Humans
Immunotherapy
Male
Methotrexate
Prognosis
Psoriasis
Risk Assessment
Severity of Illness Index
T-Lymphocytes
Treatment Outcome
authors with profiles
Kenneth Gordon